INTERNATIONAL BIOTECHNOLOGY TRUST PLC - PTC THERAPEUTICS INC ownership

PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 184 filers reported holding PTC THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of PTC THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$380,630
-45.0%
17,0000.0%0.13%
-39.3%
Q2 2023$691,730
-84.6%
17,000
-81.7%
0.21%
-83.2%
Q1 2023$4,504,920
-18.0%
93,000
-35.4%
1.26%
-25.9%
Q4 2022$5,493,600
+420.7%
144,000
+585.7%
1.70%
+402.1%
Q3 2022$1,055,000
-95.0%
21,000
+2394.1%
0.34%
+54.3%
Q2 2022$21,000,000
+3303.6%
842
-99.8%
0.22%
+57.6%
Q1 2022$617,000
-96.5%
411,000
-8.5%
0.14%
-96.5%
Q4 2021$17,884,000
+7.0%
449,0000.0%3.98%
-1.2%
Q3 2021$16,712,000
-11.8%
449,0000.0%4.03%
-19.4%
Q2 2021$18,948,000
-1.9%
449,000
+10.0%
5.00%
-2.1%
Q1 2021$19,319,000
-4.9%
408,000
+22.5%
5.11%
-7.9%
Q4 2020$20,323,000
+45.7%
333,000
+11.4%
5.55%
+23.2%
Q3 2020$13,951,000
-7.8%
299,0000.0%4.50%
-10.5%
Q2 2020$15,135,000
+26.4%
299,000
+11.2%
5.03%
-7.8%
Q1 2020$11,971,000
+118.8%
269,000
+136.0%
5.46%
+176.9%
Q4 2019$5,470,000
-31.5%
114,000
-51.7%
1.97%
-46.6%
Q3 2019$7,982,000
-31.4%
236,000
-8.9%
3.69%
-14.5%
Q2 2019$11,642,000
+28.6%
259,000
+7.7%
4.32%
+29.1%
Q1 2019$9,050,000240,4933.34%
Other shareholders
PTC THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Ayer Capital Management, LP 416,666$7,153,00038.92%
Novo Holdings A/S 747,359$11,210,0002.78%
Bain Capital Public Equity Management, LLC 2,333,333$50,073,0001.26%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 845,027$18,134,0000.84%
HealthCor Management, L.P. 732,200$15,713,0000.84%
RA Capital Management 300,000$6,438,0000.67%
Catalyst Capital Advisors LLC 30,666$658,0000.36%
CR Intrinsic Investors, LLC 119,237$2,559,0000.08%
Weiss Multi-Strategy Advisers LLC 284,130$6,098,0000.07%
SECTORAL ASSET MANAGEMENT INC 57,519$1,234,0000.06%
View complete list of PTC THERAPEUTICS INC shareholders